A Perspective on the Whole Foods Decision: Would the Most Important Evidence Please Stand Up?
Michael Bernstein, Deborah Feinstein, Apr 24, 2008
In the old game show, To Tell the Truth, panelists tried to convince the audience that they were the one associated with a particular story. They had to weave facts and details into the story to make it sound like the events had happened to them. The audience had to try to figure out which facts were likely to be consistent with the actual story. At the end, the host asked the real person associated with the story to stand up. Analyzing a merger has many similarities to this old game show. While hopefully no one in a merger analysis is actively trying to mislead, the decision makers must still sort through a plethora of facts to determine which are consistent with a theory that would condemn a merger versus a theory that would clear a merger. This is a particularly difficult exercise in a retail merger. There are no customers to interview and there are no customers documents from which one can glean how they might behave in the event of changes in the competitive environment. Which facts are meaningful and which are simply details that serve only to obscure the story? Which facts should be given weight and which should be ignored? And, how much weight should documentary and testimonial evidence be given as compared to economic evidence? An examination of these issues in the Whole Foods matter shows that what the U.S. Federal Trade Commission (FTC) and the district court thought the evidence showed, and what weight to give various evidence, differed so significantly that they reached entirely different conclusions about the matter.
Links to Full Content
Featured News
FTC Files Suit Against Liquor Giant Southern Glazer’s Over Discount Disparities
Dec 12, 2024 by
CPI
Racing Rivals Accuse NASCAR of Retaliation in High-Stakes Antitrust Battle
Dec 12, 2024 by
CPI
Samsung Challenges Indian Antitrust Investigation, Calls Raid “Unlawful”
Dec 12, 2024 by
CPI
European Sites Criticize Google’s Compliance Efforts with DMA
Dec 12, 2024 by
CPI
Banco BPM Overcomes Regulatory Hurdle in $1.7 Billion Bid
Dec 12, 2024 by
CPI
Antitrust Mix by CPI
Coopetition in The Pharma Industry: Challenges for Antitrust
Dec 12, 2024 by
Juan Delgado & Lourdes Sosa
Symmetry and the Sixth Force: The Essential Role of Complements
Dec 12, 2024 by
Adam Brandenburger & Barry Nalebuff
ESG Collaborations in Light of European Antitrust Policy and Enforcement Trends
Dec 12, 2024 by
Christian Ritz, Julia Gingelmaier & Kyra Harmes
Antitrust Chronicle® – Co-opetition
Dec 11, 2024 by
CPI
Antitrust Chronicle® – Moats & Entrenchment
Nov 29, 2024 by
CPI